Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo.

Landmeier S, Altvater B, Pscherer S, Meltzer J, Sebire N, Pule M, Vera J, Hotfilder M, Juergens H, Vormoor J, Rossig C

Research article (journal)

Details about the publication

JournalLeukemia
Volume24
Issue5
Page range1080-1084
StatusPublished
Release year2010
Language in which the publication is writtenEnglish
DOI10.1038/leu.2010.38
KeywordsHumans; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Bone Marrow; Immunotherapy Adoptive; Mice Inbred NOD. Receptors Immunologic; Antigens CD19. Mice; Animals; Flow Cytometry; T-Lymphocytes Cytotoxic; Mice SCID. Graft vs Leukemia Effect; Humans; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Bone Marrow; Immunotherapy Adoptive; Mice Inbred NOD. Receptors Immunologic; Antigens CD19. Mice; Animals; Flow Cytometry; T-Lymphocytes Cytotoxic; Mice SCID. Graft vs Leukemia Effect

Authors from the University of Münster

Altvater, Bianca
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)
Hotfilder, Marc
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)
Jürgens, Franz Herbert
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)
Rössig, Claudia
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)